Dermiford Cream Should Not Be Used for Mixed Bacterial-and-Fungal Skin Infections
I strongly recommend against using Dermiford cream (or any multi-ingredient combination containing a potent corticosteroid, antibiotics, and antifungals) for mixed skin infections. This type of combination product is inappropriate, potentially harmful, and contradicts evidence-based dermatology practice.
Why This Combination Is Problematic
The Corticosteroid Component Creates Serious Risks
The inclusion of clobetasol (a super-potent topical corticosteroid) in a multi-ingredient cream for infections is fundamentally flawed:
- Corticosteroids suppress local immune responses, which can worsen both bacterial and fungal infections rather than treat them
- High-potency steroids like clobetasol cause skin atrophy, striae, and other irreversible damage, especially on sensitive areas (face, groin, axillae) where mixed infections commonly occur 1, 2
- The evidence shows combination corticosteroid-antifungal products have decreased efficacy in clearing fungal infections compared to antifungal monotherapy 2
Evidence Against Combination Products
Research specifically examining corticosteroid-antimicrobial combinations demonstrates:
- Treatment failure rates are higher with combinations versus single-agent therapy 2
- Serious adverse effects including striae, hirsutism, and in children, growth retardation 2
- These products are "considerably more expensive" and "less cost effective than antifungal monotherapy" 2
- A 2021 study found that 48.9% of prescriptions for clotrimazole-betamethasone were written for sensitive areas where they should not be used 1
The Correct Approach to Mixed Infections
Step 1: Establish the Diagnosis
- Obtain KOH preparation and/or fungal culture to confirm fungal infection 3
- Obtain bacterial culture if secondary infection is suspected
- Do not treat empirically with combination products
Step 2: Treat Based on Confirmed Pathogens
For fungal infections (tinea, candidiasis):
- Use topical antifungal monotherapy once to twice daily 4, 3
- Ketoconazole 2% cream: Apply once daily for 2 weeks (candidiasis, tinea corporis/cruris) or 6 weeks (tinea pedis) 4
- Alternatives include terbinafine, other azoles, or tolnaftate 3
For confirmed bacterial superinfection:
- Add appropriate topical or systemic antibiotics separately based on culture results 5, 6
- Treatment duration: 7-14 days for most bacterial skin infections 5
For severe or refractory fungal infections:
- Consider oral antifungals (terbinafine, itraconazole, or fluconazole) rather than adding corticosteroids 3
Step 3: Address Inflammation Separately (If Needed)
If significant inflammation requires treatment after infection is controlled:
- Use a lower-potency corticosteroid separately and for limited duration
- Never combine with antimicrobials in the same formulation
- Limit use to 2 consecutive weeks maximum 7
Critical Contraindications
Absolute contraindications for clobetasol-containing combinations:
- Active skin infections (bacterial, fungal, or viral) without appropriate antimicrobial coverage
- Children under 12 years of age
- Face, groin, or axillae (sensitive areas)
- Use exceeding 2 consecutive weeks 7
- Hypersensitivity to any component 4
Common Pitfalls to Avoid
- Do not prescribe "shotgun" combination products hoping to cover all possibilities—this leads to treatment failure and adverse effects
- Do not use super-potent corticosteroids (like clobetasol) on infected skin
- Do not treat without confirming the diagnosis—clinical diagnosis of tinea has low accuracy 3
- Do not exceed recommended treatment durations for topical antifungals (2-6 weeks depending on site) 4
The Bottom Line
Use targeted monotherapy based on confirmed diagnosis. If both bacterial and fungal infections are definitively present, treat each with appropriate single-agent antimicrobials prescribed separately, never in a corticosteroid-containing combination. The evidence consistently shows that multi-ingredient corticosteroid-antimicrobial combinations like Dermiford cream are associated with treatment failure, increased adverse effects, and higher costs compared to rational single-agent therapy 1, 2.